In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at GBX 95 GBX in weekly data.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Low profitability weakens the company.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
With an enterprise value anticipated at 5.88 times the sales for the current fiscal year, the company turns out to be overvalued.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.